Pfizer and BioNTech seek emergency use authorization for Corona vaccine for kids below 5 years of age

Pharma companies Pfizer and BioNTech have sought emergency use authorization for Covid-19 vaccine for kids below 5 years of age.

In a statement, Pfizer said, three doses of the vaccine will be needed for children between 6 months and 4 years of age to achieve high levels of protection against current and potential future variants of Corona. If authorization is granted, the Pfizer-BioNTech vaccine will be the first COVID-19 vaccine available for paediatric populations under 5 years of age.